机构地区:[1]陆军军医大学第一附属医院输血科,重庆400030 [2]陆军第七十三集团军医院输血科,福建厦门361000
出 处:《中国输血杂志》2024年第12期1365-1370,共6页Chinese Journal of Blood Transfusion
摘 要:目的建立1种全新的离心-膜杂合式血浆置换(centrifugal-membrane hybrid plasmapheresis,CMHP)模式,通过与离心式治疗性血浆置换(centrifugation therapeutic plasma exchange,cTPE)比较,观察其治疗高脂血症的临床效果、安全性及优势。方法回顾性分析2021年8月至2023年9月在本科治疗的47例高脂血症患者,共60次治疗。分为2组:CMHP组37例患者,46次治疗;cTPE组10例患者,14次治疗。CMHP组采用血细胞分离机分离血浆+二级膜血浆成分分离器分离血浆成分的脂蛋白单采技术,cTPE组采用血细胞分离机分离血浆进行治疗性血浆置换。对比2组的临床效果、安全性及优势。结果CMHP组治疗前后总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)及低密度脂蛋白胆固醇(LDL-C)下降率分别为68.56%[59.81%,73.42%]、65.80%[55.55%,75.98%]、46.57%[36.02%,54.83%]及66.67%[43.48%,76.24%],差异具有统计学意义(P<0.001)。cTPE组治疗前后TC、TG及HDL-C下降率分别为42.52%[29.67%,49.85%]、52.32%[38.43%,67.07%]及22.36%[8.51%,33.65%],差异具有统计学意义(P<0.05)。CMHP组血浆处理倍数1.48(0.29)[均数(标准差)]明显高于cTPE组0.87(0.26),差异具有统计学意义(P<0.001),导致CMHP组的TC及HDL-C下降率均高于cTPE组,差异具有统计学意义(P<0.001),而2组的TG下降率差异不具统计学意义(P>0.05)。同时cTPE组需输入血浆1520.00 mL[1462.50 mL,2000.00 mL],而CMHP组实现了血液的零输入。CMHP组不良反应率6.52%(3/46),cTPE组为7.14%(1/14),差异不具统计学意义(P>0.05)。结论CMHP较cTPE能够更好地降低血脂水平,且无需任何血液制品,避免了血液传染病的传播,不良反应发生率低,具有较好的临床应用前景。Objective To establish a new centrifugal-membrane hybrid plasmapheresis(CMHP)model,and observe its clinical efficacy,safety and advantages in the treatment of hyperlipidemia by comparing with centrifugation therapeutic plasma exchange(cTPE).Methods A retrospective analysis was performed on 47 patients with hyperlipidemia treated in our department from August 2021 to September 2023,with a total of 60 treatments.They were divided into two groups:CM-HP group with 37 patients and 46 treatments;cTPE group included 10 patients with 14 treatments.In the CMHP group,the plasma was separated by a blood cell separator and the plasma components were separated by a two-stage membrane plasma component separator.In the cTPE group,the plasma was separated by a blood cell separator for therapeutic plasma ex-change.The clinical efficacy,safety and advantages of the two groups were compared.Results The reduction ratios of to-tal cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C)and low density lipoprotein choles-terol(LDL-C)before and after treatment in CMHP group were 68.56%[59.81%,73.42%],65.80%[55.55%,75.98%]and 46.57%[36.02%,54.83%]and 66.67%[43.48%,76.24%]respectively,with statistically significant difference(P<0.001).The decrease ratios of TC,TG and HDL-C before and after treatment in cTPE group were 42.52%[29.67%,49.85%],52.32%[38.43%,67.07%]and 22.36%[8.51%,33.65%],respectively,and the difference was statistically significant(P<0.05).The plasma treatment multiple was 1.48(0.29)in CMHP group,which was signifi-cantly higher than 0.87(0.26)in cTPE group,with a statistically significant difference(P<0.001),resulting in higher TC and HDL-C reduction ratios in CMHP group than in cTPE group,with a statistically significant difference(P<0.001),while there was no significant difference in TG reduction rate between the two groups(P>0.05).At the same time,the cTPE group required 1520.00 mL[1462.50 mL,2000.00 mL]plasma input,while the CMHP group achieved zero blood input.The adverse reaction ratio was 6.52%(3/
关 键 词:离心-膜杂合式血浆置换 治疗性血浆置换 离心式 高脂血症
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...